论文部分内容阅读
我们应用深圳海王药业公司生产的新一代双膦酸盐制剂—博宁(帕米膦酸二钠)和超分割放射治疗对28例肺癌骨转移患者进行了观察,取得了较满意的临床疗效。1 材料与方法1·1 病例选择 病理组织学证实的原发性肺癌患者28例。男22例,女6例;年龄42～78岁,平均60岁。疗前DPS评分
We applied the new generation of bisphosphonate preparations produced by Shenzhen Haiwang Pharmaceutical Co., Ltd.—Berning (pamidronate disodium) and hyperfractionation radiotherapy to observe 28 patients with bone metastases from lung cancer and achieved satisfactory clinical efficacy. . 1 Materials and Methods 1. 1 Case selection 28 patients with primary lung cancer confirmed by histopathology. 22 males and 6 females; aged 42-78 years, with an average age of 60 years. Pre-treatment DPS score